A detailed history of Ziegler Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ziegler Capital Management, LLC holds 52,715 shares of ABBV stock, worth $9.65 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
52,715
Previous 28,541 84.7%
Holding current value
$9.65 Million
Previous $4.42 Million 117.07%
% of portfolio
0.34%
Previous 0.2%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $3.86 Million - $4.4 Million
24,174 Added 84.7%
52,715 $9.6 Million
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $227,590 - $256,320
-1,654 Reduced 5.48%
28,541 $4.42 Million
Q3 2023

Oct 16, 2023

SELL
$133.59 - $154.65 $786,177 - $910,115
-5,885 Reduced 16.31%
30,195 $4.5 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $5.44 Million - $6.77 Million
-41,043 Reduced 53.22%
36,080 $4.86 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $273,023 - $314,427
-1,888 Reduced 2.39%
77,123 $12.3 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $750,193 - $899,678
-5,424 Reduced 6.42%
79,011 $0
Q3 2022

Oct 25, 2022

SELL
$134.21 - $153.93 $417,527 - $478,876
-3,111 Reduced 3.55%
84,435 $11.4 Million
Q2 2022

Jul 21, 2022

BUY
$137.62 - $174.96 $1.34 Million - $1.71 Million
9,751 Added 12.53%
87,546 $13.4 Million
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $1.21 Million - $1.5 Million
-9,146 Reduced 10.52%
77,795 $12.6 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $470,006 - $594,693
-4,375 Reduced 4.79%
86,941 $11.8 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $1.45 Million - $1.64 Million
-13,613 Reduced 12.97%
91,316 $9.85 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $417,788 - $465,440
3,971 Added 3.93%
104,929 $11.8 Million
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $1.35 Million - $1.49 Million
13,200 Added 15.04%
100,958 $10.9 Million
Q4 2020

Feb 05, 2021

SELL
$80.49 - $108.67 $196,798 - $265,698
-2,445 Reduced 2.71%
87,758 $9.4 Million
Q3 2020

Oct 21, 2020

BUY
$85.91 - $100.83 $3.15 Million - $3.69 Million
36,620 Added 68.34%
90,203 $7.9 Million
Q2 2020

Jul 24, 2020

SELL
$73.37 - $98.18 $3.3 Million - $4.42 Million
-44,978 Reduced 45.63%
53,583 $5.26 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $6.36 Million - $9.64 Million
98,561 New
98,561 $7.51 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.